The Global Induced Pluripotent Stem Cell (IPSC) Market Report by The Business Research Company Covers Induced Pluripotent Stem Cell (IPSC) Market Drivers And Restraints, Induced Pluripotent Stem Cell (IPSC) Market Size, Major Players, And The Impact Of COVID-19 On The Induced Pluripotent Stem Cell (IPSC) Market.
The induced pluripotent stem cell (IPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes and neurons.
Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell.
The global induced pluripotent stem cell (IPSC) market is expected to grow from $2.22 billion in 2020 to $2.43 billion in 2021 at a compound annual growth rate (CAGR) of 9.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The induced pluripotent stem cell (IPSC) market is expected to reach $3.36 billion in 2025 at a CAGR of 8.4%.
Request A Sample For The Global Induced Pluripotent Stem Cell (IPSC) Market Report:
Some induced pluripotent stem cell market trends include regulation by NIH. National Institute of Health (NIH), a part of Department of Health and Human Services, regulates the market for IPSCs in the US. If a company is using, making or planning to acquire IPSCs, they are required to provide some information.
Global induced pluripotent stem cell (IPSC) market segments include:
1) By Derived Cell Type: Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Others.
2) By Application: Academic Research, Drug Development And Discovery, Toxicity Screening, Regenerative Medicine.
3) By End-User: Hospitals, Research Laboratories.
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021: COVID-19 Growth And Change To 2030 At:
The Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides induced pluripotent stem cell (IPSC) market overviews, analyzes and forecasts market size, share, induced pluripotent stem cell (IPSC) market players, induced pluripotent stem cell (IPSC) market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The induced pluripotent stem cell (IPSC) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021: COVID-19 Growth And Change To 2030 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country, Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries.
Market Players Covered: Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc., Fate Therapeutics, ViaCyte, StemCells, Japan Tissue Engineering Co. Ltd, Fate Therapeutics, Japan Tissue Engineering Co, Ncardia, Axol Bioscience, ORIG3N, Lonza, REPROCELL, BRISTOL-MYERS SQUIBB (IPIERIAN), VIACYTE INC., ABM (APPLIED BIOLOGICAL MATERIALS INC.), ADDGENE, ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC., ALSTEM LLC, APPLIED STEMCELL INC., ATCC, AXIOGENESIS AG, AXOL BIOSCIENCEE, BIO-TECHNE, BLUEROCK THERAPEUTICS, GENTARGET INC., ID PHARMA CO. LTD., INVIVOGEN.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing And Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The Induced Pluripotent Stem Cell (IPSC) Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The Induced Pluripotent Stem Cell (IPSC) Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
Here is a list of reports from The Business Research Company similar to the Induced Pluripotent Stem Cell (IPSC) Global Market Report 2021: